Cognitive dysfunction, including significant impairments in learning, behavior, and attention, is found in over 10% of children in the general population. However, in the common inherited cancer predisposition syndrome, neurofibromatosis type 1 (NF1), the prevalence of these cognitive deficits approaches 70%. As a monogenic disorder, NF1 provides a unique genetic tool to identify and dissect mechanistically the molecular and cellular bases underlying cognitive dysfunction. In this review, we discuss Nf1 fly and mouse systems that mimic many of the cognitive abnormalities seen in children with NF1. Further, we describe discoveries from these models that have uncovered defects in the regulation of Ras activity, cAMP generation, and dopamine homeostasis as key mechanisms important for cognitive dysfunction in children with NF1.
Introduction NF1 is one of the most common neurogenetic disorders affecting the nervous system. The hallmark of NF1 is the development of tumors involving the central and peripheral nervous systems. In this condition, affected individuals are prone to the formation of peripheral nerve sheath tumors (i.e., neurofibromas, plexiform neurofibromas, and malignant peripheral nerve sheath tumors) and brain tumors (optic pathway gliomas and malignant gliomas). Moreover, 50-70% of children with NF1 manifest specific cognitive impairments, including difficulties with attention, executive function, language, visual perception, and learning [1] [2] [3] [4] . Although most children exhibit some form of cognitive deficit that negatively impacts upon their scholastic performance, the specific cognitive abnormality present (i.e., attention deficit, spatial memory impairment, fine motor delay) and the severity of the deficit varies greatly from child to child.
In concert with clinical studies characterizing the spectrum of learning, behavioral, and motor delays in children with NF1, laboratory investigations have begun to define the molecular and cellular etiologies for these common problems. Using Nf1 genetically engineered strains of mice and flies, investigators have successfully modeled many of the cognitive and behavioral deficits seen in children with NF1, and employed these model systems to better define the role of the NF1 protein (neurofibromin) in normal central nervous system (CNS) neuronal function. This review will highlight the basic neurobiological insights that have derived from the use of these robust preclinical strains as well as their importance for the identification and validation of new therapeutic drug targets relevant to the treatment of children with NF1.
Clinical features of NF1
NF1 is a common nervous system disorder, affecting 1 in 3500 people globally [5] . NF1 is inherited in an autosomal dominant manner, although $50% of individuals present with de novo mutations, and represent the first member of their family with NF1 [6] . Although NF1 genetic testing is available for select individuals, the diagnosis of NF1 is most often established on clinical grounds (Table 1) . To be given the diagnosis of NF1, individuals must have at least two features of the condition, including greater than five café-au-lait macules (birthmarks), skinfold (underarm or groin) freckling, Lisch nodules (iris hamartomas), neurofibromas, an optic pathway glioma, a distinctive bone abnormality (i.e., tibial dysplasia), or a first degree relative with NF1 [7] . In addition to these features, individuals with NF1 may also manifest learning/behavioral problems, malignant gliomas, T2 hyperintensities on neuroimaging (i.e., magnetic resonance imaging) studies, enlarged heads (macrocephaly), gross and fine motor delays, short stature, and other less common cancers [8] [9] [10] [11] [12] [13] .
Cognitive and behavioral deficits in children with NF1 Cognitive problems are the most frequently observed neurological impairments in children with NF1. The majority of children display some degree of cognitive deficits [1], which limit their full academic achievement and overall quality of life. Clinical studies examining cognitive problems in NF1 have revealed a left shift in average IQ, ranging from low to normal IQs, with specific learning deficits being observed in 30-70% of children [1, 14, 15] . Additionally, children with NF1 exhibit poor performance on tasks of reading, spelling, and mathematics, impaired expressive and receptive language skills, deficits in visuospatial and visuoperceptual skills, and defects in executive function (planning and concept formation) [1, 16, 17] . Although less common, there is also an increased incidence of autistic spectrum disorder in children with NF1 [18] . Problems with attention and behavior in children with NF1 can also negatively affect school performance and social interactions [19] [20] [21] . Nearly 70% of children with NF1 report deficits in one or more of the attention system
